TRP-2 tetramer technology: A key tool in melanoma immunology research

Author: Senior Product Manager of UA Views：13

This article focuses on the technical principles of the TRP-2 epitope peptide and its MHC tetramer, systematically elaborating on the molecular characteristics of the mouse TRP-2 (180-188) epitope peptide, its immune recognition mechanism, and its application value in melanoma immunotherapy.

Recent Advances
Product Information

Recent Advances

TRP-2 Tetramer Technology: A Key Tool for Melanoma Immunotherapy Research

Summary
This article systematically elaborates on the molecular characteristics, immune recognition mechanisms, and application value of the murine TRP-2 (180-188) epitope peptide and its MHC tetramer in melanoma immunotherapy.

I. Molecular Characteristics and Immunological Basis of TRP-2 Epitope Peptide

Tyrosinase-related protein 2 (TRP-2) is a key enzyme involved in melanin biosynthesis in melanocytes and one of the most important tumor-associated antigens in melanoma immunotherapy. TRP-2 is expressed at low levels in normal melanocytes but significantly upregulated in melanoma cells, making it an ideal target for tumor immunotherapy.

The murine TRP-2 (180-188) epitope peptide (amino acid sequence SVYDFFVWL) corresponds to residues 180–188 of the TRP-2 protein. This 9-mer peptide was identified as the dominant reactive epitope by cytotoxic T lymphocytes (CTLs) targeting B16 melanoma cells. The peptide adopts a specific conformation in acidic environments (isoelectric point ~3.8) and is efficiently presented by the murine MHC class I molecule H-2K(b), playing a central role in melanoma immunology research.

II. MHC-Peptide Complex and T Cell Recognition Mechanism

Immune recognition of tumor antigen epitopes depends on MHC-mediated antigen presentation. After degradation by proteasomes in melanoma cells, the SVYDFFVWL epitope peptide binds to H-2K(b) molecules in the endoplasmic reticulum, forming stable MHC-peptide complexes that are transported to the tumor cell surface via the Golgi apparatus. These complexes are specifically recognized by TCRs on CD8⁺ cytotoxic T lymphocytes, initiating T cell activation signals. Activated CTLs directly lyse TRP-2-positive tumor cells through perforin and granzyme release while secreting cytokines like IFN-γ and TNF-α to inhibit tumor angiogenesis and recruit other immune cells.

Based on this mechanism, fluorescence-labeled MHC-peptide tetramer technology utilizes a biotin-streptavidin system to assemble four biotinylated H-2K(b)/SVYDFFVWL complexes with fluorescently labeled streptavidin, forming stable tetrameric complexes. This multivalent design enhances TCR binding affinity, enabling direct identification and quantification of TRP-2-specific CD8⁺ T cells without in vitro antigen stimulation or expansion.

III. Applications of TRP-2 Tetramers in Immune Monitoring and Therapy Evaluation

In tumor vaccine development, TRP-2 tetramers can monitor the frequency and dynamics of TRP-2-specific CD8⁺ T cells in peripheral blood and spleen after immunization with TRP-2-loaded dendritic cell vaccines or synthetic peptide vaccines. For adoptive T cell therapy, this tool evaluates the proportion of TRP-2-specific CTLs in expanded cell products to ensure quality. In combination therapy studies (e.g., TRP-2 vaccines with PD-1/PD-L1 checkpoint inhibitors), the tetramer assesses synergistic effects on T cell responses. Additionally, in TRP-2-specific TCR-T or CAR-T cell development, it serves as a critical quality control tool to verify antigen-binding specificity.

IV. Conclusion

As one of the most important shared tumor antigens in melanoma immunotherapy, TRP-2 and its H-2K(b)-restricted epitope SVYDFFVWL are widely used in vaccine research and adoptive T cell therapy evaluation. APC-labeled MHC tetramers based on this epitope provide a precise and efficient tool for single-cell quantification and analysis of TRP-2-specific CD8⁺ T cell responses, offering broad applications in melanoma immunology research and immunotherapy product development.

To meet these research needs, U-Enjoy offers UA-MHC H-2K(b)/SVYDFFVWL TRP2 Tetramer-APC Labelled. This product contains correctly folded biotinylated H-2K(b) molecules complexed with SVYDFFVWL peptide, assembled into tetramers with APC-labeled streptavidin. APC has an excitation maximum at 633–647 nm and emission maximum at 660 nm, compatible with flow cytometers equipped with red lasers (633/640 nm). It specifically identifies TRP-2 (180-188)-specific CD8⁺ T cells for applications including antigen-specific T cell response analysis in B16 melanoma models, pharmacodynamic evaluation of TRP-2-targeted therapies, and immunogenicity testing of tumor vaccines. For optimal results, titration is recommended per the product manual, with light-protected handling throughout staining procedures.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next